157 related articles for article (PubMed ID: 22172395)
1. Synthesis, radioiodination and in vitro and in vivo sigma receptor studies of N-1-allyl-N´-4-phenethylpiperazine analogs.
Lever SZ; Xu R; Fan KH; Fergason-Cantrell EA; Carmack TL; Watkinson LD; Lever JR
Nucl Med Biol; 2012 Apr; 39(3):401-14. PubMed ID: 22172395
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro evaluation of iodinated derivatives of piperazine as a new ligand for sigma receptor imaging by single photon emission computed tomography.
Hirata M; Mori T; Soga S; Umeda T; Ohmomo Y
Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):470-5. PubMed ID: 16595947
[TBL] [Abstract][Full Text] [Related]
3. Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters.
Xu R; Lord SA; Peterson RM; Fergason-Cantrell EA; Lever JR; Lever SZ
Bioorg Med Chem; 2015 Jan; 23(1):222-30. PubMed ID: 25468036
[TBL] [Abstract][Full Text] [Related]
4. Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503.
Lever JR; Gustafson JL; Xu R; Allmon RL; Lever SZ
Synapse; 2006 May; 59(6):350-8. PubMed ID: 16463398
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of [
Shigeno T; Kozaka T; Kitamura Y; Ogawa K; Taki J; Kinuya S; Shiba K
Ann Nucl Med; 2021 Feb; 35(2):167-175. PubMed ID: 33417152
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 11C- and 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies.
Kawamura K; Elsinga PH; Kobayashi T; Ishii S; Wang WF; Matsuno K; Vaalburg W; Ishiwata K
Nucl Med Biol; 2003 Apr; 30(3):273-84. PubMed ID: 12745019
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of radioiodinated 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-piperazine derivatives as new ligands for sigma receptor imaging using single photon emission computed tomography.
Hirata M; Mori T; Soga S; Umeda T; Ohmomo Y
Biol Pharm Bull; 2006 Oct; 29(10):2009-15. PubMed ID: 17015942
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands.
Moussa IA; Banister SD; Beinat C; Giboureau N; Reynolds AJ; Kassiou M
J Med Chem; 2010 Aug; 53(16):6228-39. PubMed ID: 20662542
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of ¹⁸F labeled fluoro-oligo-ethoxylated 4-benzylpiperazine derivatives for sigma-1 receptor imaging.
Wang X; Li Y; Deuther-Conrad W; Xie F; Chen X; Cui MC; Zhang XJ; Zhang JM; Steinbach J; Brust P; Liu BL; Jia HM
Bioorg Med Chem; 2013 Jan; 21(1):215-22. PubMed ID: 23199475
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography.
Kawamura K; Tsukada H; Shiba K; Tsuji C; Harada N; Kimura Y; Ishiwata K
Nucl Med Biol; 2007 Jul; 34(5):571-7. PubMed ID: 17591557
[TBL] [Abstract][Full Text] [Related]
11. Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[
Sadeghzadeh M; Alirezapour B; Charkhlooie GA; Baghery MK; Khorouti A
Ann Nucl Med; 2017 May; 31(4):335-346. PubMed ID: 28315150
[TBL] [Abstract][Full Text] [Related]
12. Characterization of novel N,N'-disubstituted piperazines as sigma receptor ligands.
Zhang Y; Williams W; Torrence-Campbell C; Bowen WD; Rice KC
J Med Chem; 1998 Dec; 41(25):4950-7. PubMed ID: 9836612
[TBL] [Abstract][Full Text] [Related]
13. Effects of linker elongation in a series of N-(2-benzofuranylmethyl)-N'-(methoxyphenylalkyl)piperazine σ₁ receptor ligands.
Moussa IA; Banister SD; Akladios FN; Chua SW; Kassiou M
Bioorg Med Chem Lett; 2011 Oct; 21(19):5707-10. PubMed ID: 21871797
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
[TBL] [Abstract][Full Text] [Related]
15. [11C]Raclopride binding was reduced in vivo by sigma(1) receptor ligand SA4503 in the mouse brain, while [11C]SA4503 binding was not by raclopride.
Ishiwata K; Kobayashi T; Kawamura K; Matsuno K; Senda M
Nucl Med Biol; 2001 Oct; 28(7):787-92. PubMed ID: 11578899
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor.
Elsinga PH; Kawamura K; Kobayashi T; Tsukada H; Senda M; Vaalburg W; Ishiwata K
Synapse; 2002 Mar; 43(4):259-67. PubMed ID: 11835521
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
John CS; Gulden ME; Vilner BJ; Bowen WD
Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of N-(3-phenylpropyl)-N'-benzylpiperazines: Potent ligands for sigma1 and sigma2 receptors.
Nahas RI; Lever JR; Lever SZ
Bioorg Med Chem; 2008 Jan; 16(2):755-61. PubMed ID: 18029187
[TBL] [Abstract][Full Text] [Related]
19. Tactics for preclinical validation of receptor-binding radiotracers.
Lever SZ; Fan KH; Lever JR
Nucl Med Biol; 2017 Jan; 44():4-30. PubMed ID: 27755986
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
